Rohto's Original Milk Peptide Found to Act on Growing Muscles, Not Just Bones and Blood
NQ Score
0/100
N1 Content Completeness
8
AI Summary (NQ-processed)
A joint study by Rohto Pharmaceutical and Mie University has revealed that Rohto's proprietary ingredient 'Oligomil® (milk peptide)' may act on growing muscles (especially fast-twitch muscles) and improve motor performance. The findings were presented at the 99th Annual Meeting of the Japanese Pharmacological Society.
AI Analysis
Frequently Asked Questions
- Q: What products use Oligomil®?
- A: Currently in the material development stage, but future application in functional foods and supplements is expected.
- Q: Will this research have the same effect on humans?
- A: This study used zebrafish; human efficacy needs to be confirmed in future research.
- Q: What is Rohto's corporate vision?
- A: The Rohto Group Integrated Management Vision 2030 is 'Connect for Well-being & Longevity'.